Cube Dx

Cube Dx is an Austrian molecular diagnostics company developing and commercializing multiplex in vitro diagnostic tests for rapid detection of pathogens and resistance markers in severe infections. Its core platform combines the proprietary hybcell cylindrical microarray, compact sequencing workflow, and the automated hyborg instrument to identify bacteria, fungi, and resistance genes directly from clinical samples. The company emphasizes early diagnosis of sepsis from whole blood in about 3 hours and also offers testing workflows for pneumonia and positive blood cultures. Cube Dx develops, produces, and distributes laboratory diagnostic assays for use in clinical routine laboratories, positioning itself as a diagnostics platform company rather than a therapeutics developer.